See every side of every news story
Get Started
SubscribeLogin
Pope Francis
Donald Trump
Vladimir Putin
Elon Musk
Israel-Hamas Conflict
Basketball
Premier League
Immigration
CPAC
Vatican
Wrestling
Baseball
Published • loading... • Updated

Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS - PressReach

Summary by pressreach.com
NANTONG and SUZHOU, China, Dec. 24, 2024 /PRNewswire/ — Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing RNA-based innovative therapies, today announced the successful dosing of the first patient in the Phase I clinical trial of RAG-17, an innovative siRNA therapy targeting Amyotrophic Lateral Sclerosis (ALS) associated with superoxide dismutase 1 (SOD1) gene mutations at Second Affiliated Hospital of Zhejia…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
pressreach.compressreach.com

Ractigen Therapeutics Announces First Patient Dosed in Phase I Clinical Trial for RAG-17 in SOD1-ALS - PressReach

NANTONG and SUZHOU, China, Dec. 24, 2024 /PRNewswire/ — Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing RNA-based innovative therapies, today announced the successful dosing of the first patient in the Phase I clinical trial of RAG-17, an innovative siRNA therapy targeting Amyotrophic Lateral Sclerosis (ALS) associated with superoxide dismutase 1 (SOD1) gene mutations at Second Affiliated Hospital of Zhejia…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pressreach.com broke the news in on Wednesday, December 25, 2024.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Nantong

Nantong

News
For You
Search
BlindspotLocal